Economic evaluation assesses delivery models for cervical cancer screening using HPV self-collection in low-income settings, highlighting cost-effective strategies.
Health Policy and Planning, doi: 10.1093/heapol/czw182. The following conflict of interest statement was missing: Dr Jose Jeronimo was the co-owner and Deputy Manager of Onco Prev International, a Peruvian company, from 2012 through March 2017. Onco Prev offers cervical cancer screening services and in 2016 also began positioning for distribution of medical devices including colposcopes and the Liger thermocoagulator. Onco Prev International did not commercialize any medical instrument during the time Dr Jeronimo was part of the company.
No takes yet. Share an insight, caveat, or question.
Campos et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: